Filing Details
- Accession Number:
- 0001140361-18-030746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-29 17:24:27
- Reporting Period:
- 2018-06-26
- Accepted Time:
- 2018-06-29 17:24:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012477 | Avadel Pharmaceuticals Plc | FLML | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1461953 | F Michael Kanan | Block 10-1, Blanchardstown Corporate Park, Ballycoolin Dublin L2 15 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Adss | Acquisiton | 2018-06-26 | 1,967 | $5.70 | 37,967 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Adss | Stock Option (right to buy) | $16.21 | 2025-10-28 | 100,000 | 100,000 | Direct | |
| Adss | Stock Option (right to buy) | $10.40 | 2026-12-14 | 100,000 | 100,000 | Direct | |
| Adss | Stock Option (right to buy) | $8.95 | 2027-12-12 | 80,000 | 80,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-10-28 | 100,000 | 100,000 | Direct |
| 2026-12-14 | 100,000 | 100,000 | Direct |
| 2027-12-12 | 80,000 | 80,000 | Direct |
Footnotes
- The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- Includes (a) 18,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/14/2016, all of which will be issued to the reporting person on the second anniversary of the grant date; and (b) 18,000 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, under which 12,000 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 6,000 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until the applicable anniversary of the date of grant).
- Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 10/28/2015 grant date.
- Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
- Options become exercisable as to 20,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
Billionaire Hedge Funds
